Trial 4: Clinical Trial with Advair HFA 230 mcg/21 mcg A active-controlled, 12-week, non-US trial compared Advair HFA 230 mcg/21 mcg with fluticasone propionate CFC inhalation aerosol 220 mcg ...
GSK can breathe easy as new CEO Emma Walmsley takes over, following the FDA rejection of Mylan’s generic version of big-selling respiratory drug Advair. The US patent on Advair (fluticasone ...
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback